5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate has been researched along with hydrazine in 1 studies
| Studies (5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate) | Trials (5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate) | Recent Studies (post-2010) (5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate) | Studies (hydrazine) | Trials (hydrazine) | Recent Studies (post-2010) (hydrazine) |
|---|---|---|---|---|---|
| 19 | 0 | 0 | 12,034 | 330 | 3,193 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garthwaite, G; Garthwaite, J; Goodwin, DA | 1 |
1 other study(ies) available for 5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate and hydrazine
| Article | Year |
|---|---|
Nitric oxide stimulates cGMP formation in rat optic nerve axons, providing a specific marker of axon viability.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Axons; Biomarkers; Cell Hypoxia; Cell Survival; Cyclic GMP; Glucose; Hydrazines; Immunohistochemistry; In Vitro Techniques; Neuroprotective Agents; Nitric Oxide; Nitrogen Oxides; Optic Nerve; Phosphodiesterase Inhibitors; Piperazines; Pyrimidines; Rats; Rats, Wistar | 1999 |